Ketamine—50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ketamine—50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms
Authors
Keywords
-
Journal
Pharmacological Reports
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-21
DOI
10.1007/s43440-021-00232-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder
- (2021) Adriana Feder et al. AMERICAN JOURNAL OF PSYCHIATRY
- Dynamics of Ketamine-induced Loss and Return of Consciousness across Primate Neocortex
- (2020) Jesus J. Ballesteros et al. ANESTHESIOLOGY
- Ketamine normalizes subgenual cingulate cortex hyper-activity in depression
- (2020) Laurel S. Morris et al. NEUROPSYCHOPHARMACOLOGY
- Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin
- (2020) Chadi G. Abdallah et al. NEUROPSYCHOPHARMACOLOGY
- Encoding, Consolidation, and Renormalization in Depression: Synaptic Homeostasis, Plasticity, and Sleep Integrate Rapid Antidepressant Effects
- (2020) Tomi Rantamäki et al. PHARMACOLOGICAL REVIEWS
- Ketamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines
- (2020) Farhan Ali et al. Nature Communications
- Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression
- (2020) Cristan A. Farmer et al. NEUROPSYCHOPHARMACOLOGY
- Ketamine Blocks Morphine-Induced Conditioned Place Preference and Anxiety-Like Behaviors in Mice
- (2020) Greer McKendrick et al. Frontiers in Behavioral Neuroscience
- Can ‘Floating’ Predict Treatment Response to Ketamine? Data from Three Randomized Trials of Individuals with Treatment-Resistant Depression
- (2020) Elia E. Acevedo-Diaz et al. JOURNAL OF PSYCHIATRIC RESEARCH
- A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression
- (2020) Paulo R. Shiroma et al. Translational Psychiatry
- Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial
- (2020) Rebecca L Rothberg et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Time is of the essence: Coupling sleep-wake and circadian neurobiology to the antidepressant effects of ketamine
- (2020) S. Kohtala et al. PHARMACOLOGY & THERAPEUTICS
- Searching for ketamine′s antidepressant mechanisms: from synaptic plasticity to dentate gyrus cell proliferation
- (2019) Tomi Rantamäki Acta Physiologica
- TrkB neurotrophin receptor at the core of antidepressant effects, but how?
- (2019) Tomi Rantamäki CELL AND TISSUE RESEARCH
- Sleep and synaptic down-selection
- (2019) Giulio Tononi et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Optogenetic stimulation of medial prefrontal cortex Drd1 neurons produces rapid and long-lasting antidepressant effects
- (2019) Brendan D. Hare et al. Nature Communications
- The Altered-State-of-Consciousness Aspect of a Feeling of Lightness Is Reported to Be Associated with Antidepressant Benefits by Depressed Individuals Receiving Ketamine Infusions: A Systematic Analysis of Internet Video Testimonials
- (2019) Kurt Stocker et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function
- (2019) Eric W. Lumsden et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial
- (2019) Sara Costi et al. NEUROPSYCHOPHARMACOLOGY
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
- (2019) Vanina Popova et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Word to the Wise About Intranasal Esketamine
- (2019) Alan F. Schatzberg AMERICAN JOURNAL OF PSYCHIATRY
- NV-5138 as a fast-acting antidepressant via direct activation of mTORC1 signaling
- (2019) Yuto Hasegawa et al. JOURNAL OF CLINICAL INVESTIGATION
- A Single Ketamine Infusion Combined With Mindfulness-Based Behavioral Modification to Treat Cocaine Dependence: A Randomized Clinical Trial
- (2019) Elias Dakwar et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ketamine Administration During Hospitalization Is Not Associated With Posttraumatic Stress Disorder Outcomes in Military Combat Casualties
- (2019) Krista B. Highland et al. ANESTHESIA AND ANALGESIA
- Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
- (2019) Maggie Fedgchin et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression
- (2019) Ella J. Daly et al. JAMA Psychiatry
- Comment on a Word to the Wise About Intranasal Esketamine
- (2019) Wayne C. Drevets et al. AMERICAN JOURNAL OF PSYCHIATRY
- More Thoughts on Intranasal Esketamine: Response to Drevets et al.
- (2019) Alan F. Schatzberg AMERICAN JOURNAL OF PSYCHIATRY
- Electroencephalographic slow wave dynamics and loss of behavioural responsiveness induced by ketamine in human volunteers
- (2019) Jamie Sleigh et al. BRITISH JOURNAL OF ANAESTHESIA
- Enhanced mGlu5 Signaling in Excitatory Neurons Promotes Rapid Antidepressant Effects via AMPA Receptor Activation
- (2019) Amrei Holz et al. NEURON
- Ketamine and depression: a narrative review
- (2019) Alexandrine Corriger et al. Drug Design Development and Therapy
- Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3
- (2019) Rachel Ochs-Ross et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study
- (2019) Fernanda S. Correia-Melo et al. JOURNAL OF AFFECTIVE DISORDERS
- Ketamine metabolite pilot study in a suicidal depression trial
- (2019) Michael F. Grunebaum et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Ketamine-induced regulation of TrkB-GSK3β signaling is accompanied by slow EEG oscillations and sedation but is independent of hydroxynorketamine metabolites
- (2019) Samuel Kohtala et al. NEUROPHARMACOLOGY
- A Single Ketamine Infusion Combined With Motivational Enhancement Therapy for Alcohol Use Disorder: A Randomized Midazolam-Controlled Pilot Trial
- (2019) Elias Dakwar et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antidepressant and antisuicidal effects of ketamine on the functional connectivity of prefrontal cortex-related circuits in treatment-resistant depression: A double-blind, placebo-controlled, randomized, longitudinal resting fMRI study
- (2019) Mu-Hong Chen et al. JOURNAL OF AFFECTIVE DISORDERS
- Esketamine for treatment resistant depression: a trick of smoke and mirrors?
- (2019) C. Gastaldon et al. Epidemiology and Psychiatric Sciences
- Dissociating the Clinical Role and Economic Value of Intranasal Esketamine
- (2019) David Dadiomov Journal of Managed Care & Specialty Pharmacy
- Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
- (2018) Carla M. Canuso et al. AMERICAN JOURNAL OF PSYCHIATRY
- Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration
- (2018) Jennifer W. Evans et al. BIOLOGICAL PSYCHIATRY
- An Overview of Animal Models Related to Schizophrenia
- (2018) Ian R. Winship et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Convergent Mechanisms Underlying Rapid Antidepressant Action
- (2018) Panos Zanos et al. CNS DRUGS
- Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression
- (2018) Mark J. Niciu et al. JOURNAL OF AFFECTIVE DISORDERS
- Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial
- (2018) Somaye Arabzadeh et al. JOURNAL OF AFFECTIVE DISORDERS
- Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression
- (2018) C. Sophia Albott et al. JOURNAL OF CLINICAL PSYCHIATRY
- Psychedelics and the essential importance of context
- (2018) Robin L Carhart-Harris et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Repeated intranasal ketamine for treatment-resistant depression – the way to go? Results from a pilot randomised controlled trial
- (2018) Verònica Gálvez et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects
- (2018) Allison C. Nugent et al. MOLECULAR PSYCHIATRY
- Mechanisms of ketamine action as an antidepressant
- (2018) P Zanos et al. MOLECULAR PSYCHIATRY
- The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects
- (2018) Chadi G. Abdallah et al. NEUROPSYCHOPHARMACOLOGY
- 7T 1H-MRS in major depressive disorder: a Ketamine Treatment Study
- (2018) Jennifer W. Evans et al. NEUROPSYCHOPHARMACOLOGY
- (2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice
- (2018) Jun-ichi Yamaguchi et al. NEUROPSYCHOPHARMACOLOGY
- Both ketamine and NBQX attenuate alcohol drinking in male Wistar rats
- (2018) Jana Ruda-Kucerova et al. NEUROSCIENCE LETTERS
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
- (2018) Panos Zanos et al. PHARMACOLOGICAL REVIEWS
- The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?
- (2018) Chadi G. Abdallah et al. PHARMACOLOGY & THERAPEUTICS
- Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy
- (2018) Allie J. Widman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The hidden therapist: evidence for a central role of music in psychedelic therapy
- (2018) Mendel Kaelen et al. PSYCHOPHARMACOLOGY
- Ketamine-Associated Brain Changes
- (2018) Dawn F. Ionescu et al. HARVARD REVIEW OF PSYCHIATRY
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
- (2018) Ella J. Daly et al. JAMA Psychiatry
- Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
- (2018) Leor Roseman et al. Frontiers in Pharmacology
- Ketamine normalizes brain activity during emotionally valenced attentional processing in depression
- (2018) Jessica L. Reed et al. NeuroImage-Clinical
- Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study
- (2018) Yoav Domany et al. BRITISH JOURNAL OF PSYCHIATRY
- Ketamine blocks bursting in the lateral habenula to rapidly relieve depression
- (2018) Yan Yang et al. NATURE
- Synaptic Potentiation and Rapid Antidepressant Response to Ketamine in Treatment-Resistant Major Depression: A Replication Study
- (2018) Allison C. Nugent et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Efficacy of Ketamine in the Treatment of Substance Use Disorders: A Systematic Review
- (2018) Jennifer L. Jones et al. Frontiers in Psychiatry
- Efficacy and Safety of a Rapid Intravenous Injection of Ketamine 0.5 mg/kg in Treatment-Resistant Major Depression
- (2018) Sonia Vidal et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Cortical Excitability and Activation of TrkB Signaling During Rebound Slow Oscillations Are Critical for Rapid Antidepressant Responses
- (2018) Samuel Kohtala et al. MOLECULAR NEUROBIOLOGY
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
- (2018) Maurizio Fava et al. MOLECULAR PSYCHIATRY
- Fractionating Blunted Reward Processing Characteristic of Anhedonia by Over-Activating Primate Subgenual Anterior Cingulate Cortex
- (2018) Laith Alexander et al. NEURON
- Faster emergence behavior from ketamine/xylazine anesthesia with atipamezole versus yohimbine
- (2018) Lukas Mees et al. PLoS One
- Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine
- (2018) Kenichi Fukumoto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ketamine for Depression, 4: In What Dose, at What Rate, by What Route, for How Long, and at What Frequency?
- (2017) Chittaranjan Andrade JOURNAL OF CLINICAL PSYCHIATRY
- Brief isoflurane anesthesia regulates striatal AKT-GSK3β signaling and ameliorates motor deficits in a rat model of early-stage Parkinson′s disease
- (2017) Juuso V. Leikas et al. JOURNAL OF NEUROCHEMISTRY
- BDNF at the synapse: why location matters
- (2017) M Song et al. MOLECULAR PSYCHIATRY
- Engaging homeostatic plasticity to treat depression
- (2017) E R Workman et al. MOLECULAR PSYCHIATRY
- Ketamine accelerates fear extinction via mTORC1 signaling
- (2017) Matthew J. Girgenti et al. NEUROBIOLOGY OF DISEASE
- Prophylactic Ketamine Attenuates Learned Fear
- (2017) Josephine C McGowan et al. NEUROPSYCHOPHARMACOLOGY
- A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
- (2017) Gerard Sanacora et al. JAMA Psychiatry
- Profiling the MAPK/ERK dependent and independent activity regulated transcriptional programs in the murine hippocampus in vivo
- (2017) Nils Blüthgen et al. Scientific Reports
- Brief Isoflurane Anesthesia Produces Prominent Phosphoproteomic Changes in the Adult Mouse Hippocampus
- (2016) Samuel Kohtala et al. ACS Chemical Neuroscience
- Ketamine use in current clinical practice
- (2016) Mei Gao et al. ACTA PHARMACOLOGICA SINICA
- Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression
- (2016) C. K. Loo et al. ACTA PSYCHIATRICA SCANDINAVICA
- Signaling pathways regulating Homer1a expression: implications for antidepressant therapy
- (2016) Tsvetan Serchov et al. BIOLOGICAL CHEMISTRY
- Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
- (2016) Jaskaran B. Singh et al. BIOLOGICAL PSYCHIATRY
- Ketamine-induced inhibition of glycogen synthase kinase-3 contributes to the augmentation of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor signaling
- (2016) Eléonore Beurel et al. BIPOLAR DISORDERS
- Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action
- (2016) Joanna Ficek et al. BMC GENOMICS
- Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate
- (2016) Darragh Downey et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study
- (2016) Cheng-Ta Li et al. HUMAN BRAIN MAPPING
- Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects
- (2016) G M I Chowdhury et al. MOLECULAR PSYCHIATRY
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
- (2016) Ronald S Duman et al. NATURE MEDICINE
- Effects of novel small compounds targeting TrkB on neuronal cell survival and depression-like behavior
- (2016) Mayu Fukuda et al. NEUROCHEMISTRY INTERNATIONAL
- Disruption of corticocortical information transfer during ketamine anesthesia in the primate brain
- (2016) Karen E. Schroeder et al. NEUROIMAGE
- Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures
- (2016) Ashley E. Lepack et al. NEUROPHARMACOLOGY
- Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition
- (2016) Oliver H. Miller et al. NEUROPHARMACOLOGY
- Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study
- (2016) Gerard Sanacora et al. NEUROPSYCHOPHARMACOLOGY
- Ketamine Treatment and Global Brain Connectivity in Major Depression
- (2016) Chadi G Abdallah et al. NEUROPSYCHOPHARMACOLOGY
- Circadian regulation of human cortical excitability
- (2016) Julien Q. M. Ly et al. Nature Communications
- Sleep recalibrates homeostatic and associative synaptic plasticity in the human cortex
- (2016) Marion Kuhn et al. Nature Communications
- Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression
- (2016) Jorge A. Quiroz et al. JAMA Psychiatry
- Role of hippocampal p11 in the sustained antidepressant effect of ketamine in the chronic unpredictable mild stress model
- (2016) H-L Sun et al. Translational Psychiatry
- The Subgenual Anterior Cingulate Cortex in Mood Disorders
- (2016) Wayne C. Drevets et al. CNS SPECTRUMS
- Intravenous Subdissociative-Dose Ketamine Versus Morphine for Analgesia in the Emergency Department: A Randomized Controlled Trial
- (2015) Sergey Motov et al. ANNALS OF EMERGENCY MEDICINE
- Pharmacotherapy for post-traumatic stress disorder: Systematic review and meta-analysis
- (2015) Mathew Hoskins et al. BRITISH JOURNAL OF PSYCHIATRY
- Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis
- (2015) Ying Xu et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Optogenetic stimulation of infralimbic PFC reproduces ketamine’s rapid and sustained antidepressant actions
- (2015) Manabu Fuchikami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ribosomal protein S6 kinase 1 signaling in prefrontal cortex controls depressive behavior
- (2015) Jason M. Dwyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression
- (2015) Ji-chun Zhang et al. PSYCHOPHARMACOLOGY
- A systematic review and meta-analysis of ketamine for the prevention of persistent post-surgical pain
- (2014) E. D. MCNICOL et al. ACTA ANAESTHESIOLOGICA SCANDINAVICA
- Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats
- (2014) Hiroyuki Koike et al. BEHAVIOURAL BRAIN RESEARCH
- A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
- (2014) Kyle A.B. Lapidus et al. BIOLOGICAL PSYCHIATRY
- Therapeutic infusions of ketamine: Do the psychoactive effects matter?
- (2014) E. Dakwar et al. DRUG AND ALCOHOL DEPENDENCE
- Multistage drug effects of ketamine in the treatment of major depression
- (2014) Martin Walter et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Post-Traumatic Stress Disorder: Theory and Treatment Update
- (2014) Heather A. Kirkpatrick et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE
- Do the dissociative side effects of ketamine mediate its antidepressant effects?
- (2014) David A. Luckenbaugh et al. JOURNAL OF AFFECTIVE DISORDERS
- Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety
- (2014) Elizabeth D. Ballard et al. JOURNAL OF PSYCHIATRIC RESEARCH
- MAPK signaling correlates with the antidepressant effects of ketamine
- (2014) Gislaine Z. Réus et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Pilot dose–response trial of i.v. ketamine in treatment-resistant depression
- (2014) Rosalyn Lai et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine
- (2014) Oliver H Miller et al. eLife
- Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder
- (2014) Adriana Feder et al. JAMA Psychiatry
- Effective analgesia with low-dose ketamine and reduced dose hydromorphone in ED patients with severe pain
- (2013) Terence L. Ahern et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Forebrain HCN1 Channels Contribute to Hypnotic Actions of Ketamine
- (2013) Cheng Zhou et al. ANESTHESIOLOGY
- Neural Correlates of Rapid Antidepressant Response to Ketamine in Treatment-Resistant Unipolar Depression: A Preliminary Positron Emission Tomography Study
- (2013) Paul J. Carlson et al. BIOLOGICAL PSYCHIATRY
- The Effects of Subanesthetic Ketamine Infusions on Motivation to Quit and Cue-Induced Craving in Cocaine-Dependent Research Volunteers
- (2013) Elias Dakwar et al. BIOLOGICAL PSYCHIATRY
- Neural correlates of rapid antidepressant response to ketamine in bipolar disorder
- (2013) Allison C Nugent et al. BIPOLAR DISORDERS
- Ketamine for chronic pain: risks and benefits
- (2013) Marieke Niesters et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Ketamine: Use in Anesthesia
- (2013) Susan Marland et al. CNS Neuroscience & Therapeutics
- Immediate ketamine treatment does not prevent posttraumatic stress responses in an animal model for PTSD
- (2013) Alzbeta Juven-Wetzler et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Acute Suppression of Spontaneous Neurotransmission Drives Synaptic Potentiation
- (2013) E. Nosyreva et al. JOURNAL OF NEUROSCIENCE
- Reviewing the ketamine model for schizophrenia
- (2013) Joel Frohlich et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A randomized controlled trial of intranasal ketamine in migraine with prolonged aura
- (2013) S. K. Afridi et al. NEUROLOGY
- GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine
- (2013) Rong-Jian Liu et al. NEUROPSYCHOPHARMACOLOGY
- Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: Role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis
- (2013) Andrea de Bartolomeis et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Ketamine, Sleep, and Depression: Current Status and New Questions
- (2013) Wallace C. Duncan et al. Current Psychiatry Reports
- Relationship of Ketamine's Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Synaptic Potentiation Is Critical for Rapid Antidepressant Response to Ketamine in Treatment-Resistant Major Depression
- (2012) Brian R. Cornwell et al. BIOLOGICAL PSYCHIATRY
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
- (2012) James W. Murrough et al. BIOLOGICAL PSYCHIATRY
- Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression
- (2012) Xiaochen Zhao et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Human Cortical Excitability Increases with Time Awake
- (2012) Reto Huber et al. CEREBRAL CORTEX
- Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder
- (2012) Wallace C. Duncan et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder
- (2012) Lobna Ibrahim et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Biological studies of post-traumatic stress disorder
- (2012) Roger K. Pitman et al. NATURE REVIEWS NEUROSCIENCE
- Neurotrophin regulation of neural circuit development and function
- (2012) Hyungju Park et al. NATURE REVIEWS NEUROSCIENCE
- Synaptic Dysfunction in Depression: Potential Therapeutic Targets
- (2012) R. S. Duman et al. SCIENCE
- Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression
- (2011) Hiroyuki Koike et al. BEHAVIOURAL BRAIN RESEARCH
- Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
- (2011) Nanxin Li et al. BIOLOGICAL PSYCHIATRY
- Brain-Derived Neurotrophic Factor Val66Met Allele Impairs Basal and Ketamine-Stimulated Synaptogenesis in Prefrontal Cortex
- (2011) Rong-Jian Liu et al. BIOLOGICAL PSYCHIATRY
- Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice
- (2011) E Beurel et al. MOLECULAR PSYCHIATRY
- A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior
- (2011) M Carlén et al. MOLECULAR PSYCHIATRY
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- Antidepressant Drugs Transactivate TrkB Neurotrophin Receptors in the Adult Rodent Brain Independently of BDNF and Monoamine Transporter Blockade
- (2011) Tomi Rantamäki et al. PLoS One
- The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [1H]-MRS
- (2011) Gerald W. Valentine et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
- Preemptive Low-dose Epidural Ketamine for Preventing Chronic Postthoracotomy Pain
- (2010) Ho-Geol Ryu et al. CLINICAL JOURNAL OF PAIN
- The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity
- (2010) Eero Castrén et al. Developmental Neurobiology
- Depression and pain
- (2010) Michael et al. Frontiers in Bioscience-Landmark
- Enantioselective capillary electrophoresis for identification and characterization of human cytochrome P450 enzymes which metabolize ketamine and norketamine in vitro
- (2010) Simone Portmann et al. JOURNAL OF CHROMATOGRAPHY A
- A negative regulator of MAP kinase causes depressive behavior
- (2010) Vanja Duric et al. NATURE MEDICINE
- Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation?
- (2010) Xiaohua Li et al. NEUROPSYCHOPHARMACOLOGY
- Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus
- (2010) Y. I. Sheline et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- Depression, rumination and the default network
- (2010) Marc G. Berman et al. Social Cognitive and Affective Neuroscience
- Chronic Phantom Limb Pain: The Effects of Calcitonin, Ketamine, and Their Combination on Pain and Sensory Thresholds
- (2009) Urs Eichenberger et al. ANESTHESIA AND ANALGESIA
- Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression
- (2009) Rebecca B. Price et al. BIOLOGICAL PSYCHIATRY
- Perioperative ketamine does not prevent chronic pain after thoracotomy
- (2008) Christian Dualé et al. EUROPEAN JOURNAL OF PAIN
- Role of endogenous sleep-wake and analgesic systems in anesthesia
- (2008) Jun Lu et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Ketamine aggravates symptoms of acute stress disorder in a naturalistic sample of accident victims
- (2008) M. Schönenberg et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Correlation Between Ketamine and Posttraumatic Stress Disorder in Burned Service Members
- (2008) Laura L. McGhee et al. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
- (2007) Sungho Maeng et al. BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search